Skip to main content

Collections

2023


New Content ItemAging and Cellular Fate: Senescence, Death, or Cancer
Edited by Christophe Nicot, Editor-in-Chief


New Content ItemLatest Correspondence on Biomarkers for Cancer diagnosis, prognosis, and drug resistance
Edited by Christophe Nicot, Editor-in-Chief

Phase 2 and 3 studies
Edited by Christophe Nicot, Editor-in-Chief


2022


New Content ItemMolecular understanding and clinical aspects of immunotherapy in the treatment of cancer 
Edited by Christophe Nicot, Editor-in-Chief


2022 Liquid Biopsy TINYLiquid Biopsy at the Frontier of Early Detection, Prognosis and Cancer Treatments
Edited by Christophe Nicot, Editor-in-Chief


2022 Genome Editing TINYGenome Editing and the Future of Personalized and Targeted Cancer Medicine
Edited by Christophe Nicot, Editor-in-Chief


2021

2021 ImagemRNA therapies and mRNA vaccines in cancer
Edited by Christophe Nicot, Editor-in-Chief


2020

2020 imageNon-coding RNAs and RNA modifiers in cancer progression and cancer cells resistance to therapies
Edited by Christophe Nicot, Editor-in-Chief

2019

2019 imageMicrovesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies
Edited by Christophe Nicot, Editor-in-Chief 

2018

2018 imageOncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities
Edited by Christophe Nicot, Editor-in-Chief 

2017

Cancer Stem Cells
Edited by Christophe Nicot, Editor-in-Chief

2016

miRNA regulation in cancer
Edited by Christophe Nicot, Editor-in-Chief 

Annual Journal Metrics

  • 2022 Citation Impact
    37.3 - 2-year Impact Factor
    33.1 - 5-year Impact Factor
    5.740 - SNIP (Source Normalized Impact per Paper)
    8.703 - SJR (SCImago Journal Rank)

    2022 Speed
    7 days submission to first editorial decision for all manuscripts (Median)
    76 days submission to accept (Median)

    2022 Usage 
    3,062,329 downloads
    4,920 Altmetric mentions